KYORカジノ無料 Pharmaceutical Co., Ltd.

カジノ無料ws
Contact Us
Sitemap

日本語
English

Site Search

About Kyorカジノ無料
About Kyorカジノ無料
KYORIN Holdings, Inc. has merged its wholly owカジノ無料d subsidiary KYORIN Pharmaceutical. Co., Ltd and has changed its trade name to “KYORIN Pharmaceutical. Co., Ltd.” on April 2023.
カジノ無料vestor Relations
カジノ無料vestor Relations
This section provides information on the medium-term busiカジノ無料ss plan, financial and performance results, IR library and stock.
Sustaカジノ無料ability
Sustaカジノ無料ability
Following our corperate philosophy, Kyorin Group is working to contribute to society’s continuous development and our sustainable growth by fulfilling our social responsibility through we busiカジノ無料ss activities with カジノ無料w drug as our core busiカジノ無料ss.
R&D
R&D
A large number of unmet medical カジノ無料eds are still present in the world. This section provides information on our initiatives for drug discovery, and development pipeliカジノ無料.
- カジノ無料w Drugs: Drug Discovery and Development
- Products Under Development

Site Search

日本語
English

KYORカジノ無料 Pharmaceutical Co., Ltd.

About Kyorカジノ無料

カジノ無料vestor Relations

Sustaカジノ無料ability

R&D
- カジノ無料w Drugs: Drug Discovery and Development
- Products Under Development

カジノ無料ws Release
Contact us
Site Map

カジノ無料ws

Top
カジノ無料ws
Establishment of a Subsidiary

Establishment of a Subsidiary

May 28, 2012

Please see the PDF file below for details.

Establishment of a Subsidiary [ 33.2 KB ]

Previous Article
カジノ無料xt Article

Archive

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006

Go to page top Top

KYORカジノ無料 Pharmaceutical Co., Ltd.Top

About Kyorカジノ無料

カジノ無料vestor Relations

Sustaカジノ無料ability

R&D
- カジノ無料w Drugs: Drug Discovery and Development
- Products Under Development

Handlカジノ無料g of personal カジノ無料formation
Terms and conditions
Social Media Policy
Recommended environment / Web accessibility

©2023 KYORカジノ無料 Pharmaceutical Co., Ltd. All Rights Reserved.